OABIW OmniAb, Inc. - Warrant

0.3675USD-5.77%Mkt Cap: —P/E: —

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan…

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)38.46M USD
Gross Profit18.36M USD
Net Income (TTM)-64.78M USD
Revenue/Share0.31 USD
Last Price0.3675 USD
Fiscal Year End—
MR Quarter—
Employees89
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.22
EPS (TTM)—
EPS (Forward)—
52W Range
0.079385% of range0.4200
52W High0.4200 USD
52W Low0.0793 USD
Profitability
Gross Margin98.38%
Oper. Margin-49.47%
EBITDA Margin-56.16%
Profit Margin-347.04%
ROE-24.26%
ROA-21.53%
Growth
Revenue Growth244.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.45M USD
CapEx (TTM)565.00K USD
FCF Margin-0.74%
FCF Yield—
Net Debt-33.08M USD
Net Debt/EBITDA1.53
Balance Sheet
Debt/Equity0.08
Current Ratio4.80
Quick Ratio4.53
Book Value/Sh1.79 USD
Cash/Share0.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float118.24M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta1.37
S&P 52W Chg15.78%
Avg Vol (30d)7.48K
Avg Vol (10d)—
Technical Indicators
RSI (14)71.5
MACD0.0750
MACD Signal0.0550
MACD Hist.+0.0200
BB Upper0.4591 USD
BB Middle0.2143 USD
BB Lower-0.0304 USD
BB Width228.34%
ATR (14)0.0397 USD
Vol Ratio (20d)0.45x